Taiwan Liposome Company, Ltd. American Depository Shares
TLC
TLC was delisted on the 28th of September, 2021.
6 hedge funds and large institutions have $3.57M invested in Taiwan Liposome Company, Ltd. American Depository Shares in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
2% more capital invested
Capital invested by funds: $3.5M → $3.57M (+$73K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less funds holding
Funds holding: 7 → 6 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$50.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.95K |
| 3 |
Morgan Stanley
New York
|
-$1K |
TLC Hedge Fund Activity: Q4 2019 in Review
6 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Taiwan Liposome Company, Ltd. American Depository Shares (TLC) for Q4 2019, worth a combined $3.57M — up 2.1% from $3.5M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TLC and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest seller was Millennium Management, cutting an estimated $50.3K.
- 6 institutional investors held Taiwan Liposome Company, Ltd. American Depository Shares (TLC) as of Q4 2019, down from 7 in Q3 2019.
- Funds reported $3.57M of Taiwan Liposome Company, Ltd. American Depository Shares stock for Q4 2019, up 2.1% quarter-over-quarter.
- 0 funds opened new Taiwan Liposome Company, Ltd. American Depository Shares positions in Q4 2019 and 1 closed out, a net change of -1 holder.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares seller in Q4 2019 was Millennium Management, an estimated $50.3K sold.
Based on aggregated 13F filings for Q4 2019.